Brenig Therapeutics

Developer of therapeutics for neurodegenerative diseases

placeSan Diego, California, United States calendar_todayFounded 2024 language brenigther.com

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 16 times.

YearFilings
20231
20241
20252
20261

Investor mix

4 investors on record; lead investors include New Enterprise Associates.

Investor typeCountShare
Venture capital4100%
Coming soon